THE Therapeutic Goods Administration (TGA) has added a new warning about the nephrotoxic potential of clindamycin capsules and injections to the Australian Product Information.
The issue was not a previously known adverse event associated with the medication.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Feb 22
